Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Placebo-Controlled Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty

NCT05412992 is registered in ClinicalTrials.gov with Teikoku Pharma USA, Inc. as lead sponsor.

NCT NCT05412992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05412992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Placebo-Controlled Evaluation of the Dexmedetomidine Transdermal Systems for Postoperative Analgesia Following Abdominoplasty
Lead sponsor
Teikoku Pharma USA, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
July 7, 2022
Completion date
April 19, 2023
Enrollment
179 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pain, postoperative